Awardee OrganizationXAVIER UNIVERSITY OF LOUISIANA
Description
Abstract Text
The investigators at XavierUniversity of Louisiana propose a clinic, health care institution, and
community survey-based research project to assess the beliefs and behavior regarding
willingness to be vaccinated with a prospective COVID-19 vaccine among African Americans in
the Southeastern Louisiana region. The COVID-19 pandemic has disproportionately impacted
the African Americans across the United States. Louisiana ranks 1st in the nation in per capita
incidence of COVID-19. African Americans make up over 50% of the deaths of all known
COVID-19 patients in the state, while only representing about 32% of the population. With the
development of a COVID-19 vaccine on the near horizon, an urgent assessment of the African
American community’s readiness for vaccine uptake is needed to inform a pharmacist-led
intervention model that will increase vaccine uptake. The Specific Aims of this proposal are:
Specific Aim #1: To identify factors of vaccine hesitancy and the potential acceptance of a
COVID-19 vaccine among the adult African-American community in Southeastern Louisiana.
Specific Aim #2: To assess the personal and financial impact of COVID-19, knowledge of
COVID-19, as well as experience with the healthcare system with regards to COVID-19.
Specific Aim #3: To use the results of Aim #1 and #2 to inform a community pharmacist
certification course and a pharmacist led intervention model among pharmacist vaccinators.
Method: Specific Aim #1 and #2 will be assessed by a survey at the start of the study with an
abbreviated follow-up survey 9 months later from clinic, community member and community
pharmacy patient respondents. Changes in vaccine hesitancy and the impact on vaccine
uptake will be determined. Aim #3 will be assessed by a pharmacist led education intervention
model with vaccine uptake surveillance pre and post the intervention in the pharmacies.
Impact: The implications of this proposed project are to understand health related beliefs and
behaviors related to COVID-19 and vaccination and their impact on the likely uptake of a
COVID-19 vaccine among African Americans. It will also provide data to facilitate the
development of strategies to improve COVID-19 vaccination in a vulnerable community with
community pharmacists as vaccinators with a pre-and post analysis plan to assess the
intervention’s success. This grant will also facilitate training early stage investigators and
diversify the health research workforce as the majority of researchers are among
underrepresented minorities and/or women.
Public Health Relevance Statement
This project is a 2-year study to investigate vaccine hesitancy, experience with COVID-19 and
the healthcare institutional experience among African-Americans in the midst of the COVID-19
pandemic in the Southeastern Louisiana region. This informational will be correlated to
self-reported likeliness of receiving a COVID-19 vaccine, when available. Finally, the proposal
will introduce a pharmacist led education and intervention plan which will include a pre and post
surveillance of vaccine uptake in respective community pharmacies.
National Institute on Minority Health and Health Disparities
CFDA Code
310
DUNS Number
020857876
UEI
HGAAKCE3A7P7
Project Start Date
24-September-2009
Project End Date
12-November-2022
Budget Start Date
13-November-2020
Budget End Date
31-December-2020
Project Funding Information for 2021
Total Funding
$148,592
Direct Costs
$100,400
Indirect Costs
$48,192
Year
Funding IC
FY Total Cost by IC
2021
NIH Office of the Director
$148,592
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3U54MD007595-12S4
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3U54MD007595-12S4
Patents
No Patents information available for 3U54MD007595-12S4
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3U54MD007595-12S4
Clinical Studies
No Clinical Studies information available for 3U54MD007595-12S4
News and More
Related News Releases
No news release information available for 3U54MD007595-12S4
History
No Historical information available for 3U54MD007595-12S4
Similar Projects
No Similar Projects information available for 3U54MD007595-12S4